Global Human Oral Vaccine Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Human Oral Vaccine market size was valued at US$ 1451.7 million in 2023. With growing demand in downstream market, the Human Oral Vaccine is forecast to a readjusted size of US$ 2264.3 million by 2030 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Human Oral Vaccine market. Human Oral Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Oral Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Oral Vaccine market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.
Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.
Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.
Key Features:
The report on Human Oral Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Oral Vaccine market. It may include historical data, market segmentation by Type (e.g., Rotavirus Vaccine, Cholera Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Oral Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Oral Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Oral Vaccine industry. This include advancements in Human Oral Vaccine technology, Human Oral Vaccine new entrants, Human Oral Vaccine new investment, and other innovations that are shaping the future of Human Oral Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Oral Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Human Oral Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Oral Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Oral Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Oral Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Oral Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Oral Vaccine market.
Market Segmentation:
Human Oral Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Human Oral Vaccine market?
What factors are driving Human Oral Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Oral Vaccine market opportunities vary by end market size?
How does Human Oral Vaccine break out type, application?
According to our LPI (LP Information) latest study, the global Human Oral Vaccine market size was valued at US$ 1451.7 million in 2023. With growing demand in downstream market, the Human Oral Vaccine is forecast to a readjusted size of US$ 2264.3 million by 2030 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Human Oral Vaccine market. Human Oral Vaccine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Human Oral Vaccine. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Human Oral Vaccine market.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.
Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.
Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.
Key Features:
The report on Human Oral Vaccine market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Human Oral Vaccine market. It may include historical data, market segmentation by Type (e.g., Rotavirus Vaccine, Cholera Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Human Oral Vaccine market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Human Oral Vaccine market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Human Oral Vaccine industry. This include advancements in Human Oral Vaccine technology, Human Oral Vaccine new entrants, Human Oral Vaccine new investment, and other innovations that are shaping the future of Human Oral Vaccine.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Human Oral Vaccine market. It includes factors influencing customer ' purchasing decisions, preferences for Human Oral Vaccine product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Human Oral Vaccine market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Human Oral Vaccine market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Human Oral Vaccine market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Human Oral Vaccine industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Human Oral Vaccine market.
Market Segmentation:
Human Oral Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Other
- Child
- Aldult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
What is the 10-year outlook for the global Human Oral Vaccine market?
What factors are driving Human Oral Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Human Oral Vaccine market opportunities vary by end market size?
How does Human Oral Vaccine break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Oral Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Oral Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Oral Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Human Oral Vaccine Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.2.4 Other
2.3 Human Oral Vaccine Sales by Type
2.3.1 Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Human Oral Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Oral Vaccine Sale Price by Type (2019-2024)
2.4 Human Oral Vaccine Segment by Application
2.4.1 Child
2.4.2 Aldult
2.5 Human Oral Vaccine Sales by Application
2.5.1 Global Human Oral Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Human Oral Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Oral Vaccine Sale Price by Application (2019-2024)
3 GLOBAL HUMAN ORAL VACCINE BY COMPANY
3.1 Global Human Oral Vaccine Breakdown Data by Company
3.1.1 Global Human Oral Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Human Oral Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Human Oral Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Human Oral Vaccine Revenue by Company (2019-2024)
3.2.2 Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Human Oral Vaccine Sale Price by Company
3.4 Key Manufacturers Human Oral Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Oral Vaccine Product Location Distribution
3.4.2 Players Human Oral Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN ORAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Oral Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Oral Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Oral Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Oral Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Human Oral Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Oral Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Oral Vaccine Sales Growth
4.4 APAC Human Oral Vaccine Sales Growth
4.5 Europe Human Oral Vaccine Sales Growth
4.6 Middle East & Africa Human Oral Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Oral Vaccine Sales by Country
5.1.1 Americas Human Oral Vaccine Sales by Country (2019-2024)
5.1.2 Americas Human Oral Vaccine Revenue by Country (2019-2024)
5.2 Americas Human Oral Vaccine Sales by Type
5.3 Americas Human Oral Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Oral Vaccine Sales by Region
6.1.1 APAC Human Oral Vaccine Sales by Region (2019-2024)
6.1.2 APAC Human Oral Vaccine Revenue by Region (2019-2024)
6.2 APAC Human Oral Vaccine Sales by Type
6.3 APAC Human Oral Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Oral Vaccine by Country
7.1.1 Europe Human Oral Vaccine Sales by Country (2019-2024)
7.1.2 Europe Human Oral Vaccine Revenue by Country (2019-2024)
7.2 Europe Human Oral Vaccine Sales by Type
7.3 Europe Human Oral Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Oral Vaccine by Country
8.1.1 Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Oral Vaccine Sales by Type
8.3 Middle East & Africa Human Oral Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Oral Vaccine
10.3 Manufacturing Process Analysis of Human Oral Vaccine
10.4 Industry Chain Structure of Human Oral Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Oral Vaccine Distributors
11.3 Human Oral Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN ORAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Oral Vaccine Market Size Forecast by Region
12.1.1 Global Human Oral Vaccine Forecast by Region (2025-2030)
12.1.2 Global Human Oral Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Oral Vaccine Forecast by Type
12.7 Global Human Oral Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Human Oral Vaccine Product Portfolios and Specifications
13.1.3 Merck Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Human Oral Vaccine Product Portfolios and Specifications
13.2.3 GSK Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Oral Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Human Oral Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Human Oral Vaccine Product Portfolios and Specifications
13.6.3 Valneva Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications
13.7.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Human Oral Vaccine Product Portfolios and Specifications
13.8.3 Bibcol Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Human Oral Vaccine Product Portfolios and Specifications
13.9.3 PaxVax Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Human Oral Vaccine Product Portfolios and Specifications
13.10.3 Vabiotech Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications
13.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Human Oral Vaccine Product Portfolios and Specifications
13.12.3 EuBiologics Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Human Oral Vaccine Product Portfolios and Specifications
13.14.3 Bio-Med Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Oral Vaccine Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Human Oral Vaccine by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Human Oral Vaccine by Country/Region, 2019, 2023 & 2030
2.2 Human Oral Vaccine Segment by Type
2.2.1 Rotavirus Vaccine
2.2.2 Cholera Vaccine
2.2.3 Oral Polio Vaccine
2.2.4 Other
2.3 Human Oral Vaccine Sales by Type
2.3.1 Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
2.3.2 Global Human Oral Vaccine Revenue and Market Share by Type (2019-2024)
2.3.3 Global Human Oral Vaccine Sale Price by Type (2019-2024)
2.4 Human Oral Vaccine Segment by Application
2.4.1 Child
2.4.2 Aldult
2.5 Human Oral Vaccine Sales by Application
2.5.1 Global Human Oral Vaccine Sale Market Share by Application (2019-2024)
2.5.2 Global Human Oral Vaccine Revenue and Market Share by Application (2019-2024)
2.5.3 Global Human Oral Vaccine Sale Price by Application (2019-2024)
3 GLOBAL HUMAN ORAL VACCINE BY COMPANY
3.1 Global Human Oral Vaccine Breakdown Data by Company
3.1.1 Global Human Oral Vaccine Annual Sales by Company (2019-2024)
3.1.2 Global Human Oral Vaccine Sales Market Share by Company (2019-2024)
3.2 Global Human Oral Vaccine Annual Revenue by Company (2019-2024)
3.2.1 Global Human Oral Vaccine Revenue by Company (2019-2024)
3.2.2 Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)
3.3 Global Human Oral Vaccine Sale Price by Company
3.4 Key Manufacturers Human Oral Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Human Oral Vaccine Product Location Distribution
3.4.2 Players Human Oral Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR HUMAN ORAL VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Human Oral Vaccine Market Size by Geographic Region (2019-2024)
4.1.1 Global Human Oral Vaccine Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Human Oral Vaccine Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Human Oral Vaccine Market Size by Country/Region (2019-2024)
4.2.1 Global Human Oral Vaccine Annual Sales by Country/Region (2019-2024)
4.2.2 Global Human Oral Vaccine Annual Revenue by Country/Region (2019-2024)
4.3 Americas Human Oral Vaccine Sales Growth
4.4 APAC Human Oral Vaccine Sales Growth
4.5 Europe Human Oral Vaccine Sales Growth
4.6 Middle East & Africa Human Oral Vaccine Sales Growth
5 AMERICAS
5.1 Americas Human Oral Vaccine Sales by Country
5.1.1 Americas Human Oral Vaccine Sales by Country (2019-2024)
5.1.2 Americas Human Oral Vaccine Revenue by Country (2019-2024)
5.2 Americas Human Oral Vaccine Sales by Type
5.3 Americas Human Oral Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Oral Vaccine Sales by Region
6.1.1 APAC Human Oral Vaccine Sales by Region (2019-2024)
6.1.2 APAC Human Oral Vaccine Revenue by Region (2019-2024)
6.2 APAC Human Oral Vaccine Sales by Type
6.3 APAC Human Oral Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Human Oral Vaccine by Country
7.1.1 Europe Human Oral Vaccine Sales by Country (2019-2024)
7.1.2 Europe Human Oral Vaccine Revenue by Country (2019-2024)
7.2 Europe Human Oral Vaccine Sales by Type
7.3 Europe Human Oral Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Oral Vaccine by Country
8.1.1 Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024)
8.1.2 Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024)
8.2 Middle East & Africa Human Oral Vaccine Sales by Type
8.3 Middle East & Africa Human Oral Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Human Oral Vaccine
10.3 Manufacturing Process Analysis of Human Oral Vaccine
10.4 Industry Chain Structure of Human Oral Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Human Oral Vaccine Distributors
11.3 Human Oral Vaccine Customer
12 WORLD FORECAST REVIEW FOR HUMAN ORAL VACCINE BY GEOGRAPHIC REGION
12.1 Global Human Oral Vaccine Market Size Forecast by Region
12.1.1 Global Human Oral Vaccine Forecast by Region (2025-2030)
12.1.2 Global Human Oral Vaccine Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Human Oral Vaccine Forecast by Type
12.7 Global Human Oral Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Human Oral Vaccine Product Portfolios and Specifications
13.1.3 Merck Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Human Oral Vaccine Product Portfolios and Specifications
13.2.3 GSK Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Human Oral Vaccine Product Portfolios and Specifications
13.3.3 Sanofi Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Lanzhou Institute
13.4.1 Lanzhou Institute Company Information
13.4.2 Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Lanzhou Institute Main Business Overview
13.4.5 Lanzhou Institute Latest Developments
13.5 Serum Institute
13.5.1 Serum Institute Company Information
13.5.2 Serum Institute Human Oral Vaccine Product Portfolios and Specifications
13.5.3 Serum Institute Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Serum Institute Main Business Overview
13.5.5 Serum Institute Latest Developments
13.6 Valneva
13.6.1 Valneva Company Information
13.6.2 Valneva Human Oral Vaccine Product Portfolios and Specifications
13.6.3 Valneva Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Valneva Main Business Overview
13.6.5 Valneva Latest Developments
13.7 Shanghai United Cell
13.7.1 Shanghai United Cell Company Information
13.7.2 Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications
13.7.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shanghai United Cell Main Business Overview
13.7.5 Shanghai United Cell Latest Developments
13.8 Bibcol
13.8.1 Bibcol Company Information
13.8.2 Bibcol Human Oral Vaccine Product Portfolios and Specifications
13.8.3 Bibcol Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Bibcol Main Business Overview
13.8.5 Bibcol Latest Developments
13.9 PaxVax
13.9.1 PaxVax Company Information
13.9.2 PaxVax Human Oral Vaccine Product Portfolios and Specifications
13.9.3 PaxVax Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 PaxVax Main Business Overview
13.9.5 PaxVax Latest Developments
13.10 Vabiotech
13.10.1 Vabiotech Company Information
13.10.2 Vabiotech Human Oral Vaccine Product Portfolios and Specifications
13.10.3 Vabiotech Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Vabiotech Main Business Overview
13.10.5 Vabiotech Latest Developments
13.11 Tiantan Biological
13.11.1 Tiantan Biological Company Information
13.11.2 Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications
13.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Tiantan Biological Main Business Overview
13.11.5 Tiantan Biological Latest Developments
13.12 EuBiologics
13.12.1 EuBiologics Company Information
13.12.2 EuBiologics Human Oral Vaccine Product Portfolios and Specifications
13.12.3 EuBiologics Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 EuBiologics Main Business Overview
13.12.5 EuBiologics Latest Developments
13.13 Panacea Biotec Ltd
13.13.1 Panacea Biotec Ltd Company Information
13.13.2 Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications
13.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Panacea Biotec Ltd Main Business Overview
13.13.5 Panacea Biotec Ltd Latest Developments
13.14 Bio-Med
13.14.1 Bio-Med Company Information
13.14.2 Bio-Med Human Oral Vaccine Product Portfolios and Specifications
13.14.3 Bio-Med Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Bio-Med Main Business Overview
13.14.5 Bio-Med Latest Developments
13.15 Halfkin Bio-Pharmaceuticals
13.15.1 Halfkin Bio-Pharmaceuticals Company Information
13.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications
13.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Halfkin Bio-Pharmaceuticals Main Business Overview
13.15.5 Halfkin Bio-Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Oral Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Oral Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Major Players of Other
Table 7. Global Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 8. Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Human Oral Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Human Oral Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 13. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Human Oral Vaccine Revenue by Application (2019-2024)
Table 15. Global Human Oral Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Human Oral Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Human Oral Vaccine Sales by Company (2019-2024) & (K Units)
Table 18. Global Human Oral Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Human Oral Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Human Oral Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Human Oral Vaccine Producing Area Distribution and Sales Area
Table 23. Players Human Oral Vaccine Products Offered
Table 24. Human Oral Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Human Oral Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Human Oral Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Human Oral Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Human Oral Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Human Oral Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Human Oral Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Human Oral Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Human Oral Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 36. Americas Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 40. Americas Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 41. APAC Human Oral Vaccine Sales by Region (2019-2024) & (K Units)
Table 42. APAC Human Oral Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Human Oral Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Human Oral Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. APAC Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Europe Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Europe Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 52. Europe Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Human Oral Vaccine
Table 60. Key Market Challenges & Risks of Human Oral Vaccine
Table 61. Key Industry Trends of Human Oral Vaccine
Table 62. Human Oral Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Human Oral Vaccine Distributors List
Table 65. Human Oral Vaccine Customer List
Table 66. Global Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Human Oral Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Human Oral Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Human Oral Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Human Oral Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Merck Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Human Oral Vaccine Product Portfolios and Specifications
Table 82. Merck Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. GSK Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Human Oral Vaccine Product Portfolios and Specifications
Table 87. GSK Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Sanofi Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Human Oral Vaccine Product Portfolios and Specifications
Table 92. Sanofi Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Lanzhou Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications
Table 97. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lanzhou Institute Main Business
Table 99. Lanzhou Institute Latest Developments
Table 100. Serum Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Serum Institute Human Oral Vaccine Product Portfolios and Specifications
Table 102. Serum Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Serum Institute Main Business
Table 104. Serum Institute Latest Developments
Table 105. Valneva Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Valneva Human Oral Vaccine Product Portfolios and Specifications
Table 107. Valneva Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Valneva Main Business
Table 109. Valneva Latest Developments
Table 110. Shanghai United Cell Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications
Table 112. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai United Cell Main Business
Table 114. Shanghai United Cell Latest Developments
Table 115. Bibcol Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Bibcol Human Oral Vaccine Product Portfolios and Specifications
Table 117. Bibcol Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bibcol Main Business
Table 119. Bibcol Latest Developments
Table 120. PaxVax Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. PaxVax Human Oral Vaccine Product Portfolios and Specifications
Table 122. PaxVax Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. PaxVax Main Business
Table 124. PaxVax Latest Developments
Table 125. Vabiotech Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. Vabiotech Human Oral Vaccine Product Portfolios and Specifications
Table 127. Vabiotech Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vabiotech Main Business
Table 129. Vabiotech Latest Developments
Table 130. Tiantan Biological Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications
Table 132. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Tiantan Biological Main Business
Table 134. Tiantan Biological Latest Developments
Table 135. EuBiologics Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. EuBiologics Human Oral Vaccine Product Portfolios and Specifications
Table 137. EuBiologics Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. EuBiologics Main Business
Table 139. EuBiologics Latest Developments
Table 140. Panacea Biotec Ltd Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications
Table 142. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Panacea Biotec Ltd Main Business
Table 144. Panacea Biotec Ltd Latest Developments
Table 145. Bio-Med Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Bio-Med Human Oral Vaccine Product Portfolios and Specifications
Table 147. Bio-Med Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Bio-Med Main Business
Table 149. Bio-Med Latest Developments
Table 150. Halfkin Bio-Pharmaceuticals Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications
Table 152. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Halfkin Bio-Pharmaceuticals Main Business
Table 154. Halfkin Bio-Pharmaceuticals Latest Developments
Table 1. Human Oral Vaccine Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Human Oral Vaccine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Rotavirus Vaccine
Table 4. Major Players of Cholera Vaccine
Table 5. Major Players of Oral Polio Vaccine
Table 6. Major Players of Other
Table 7. Global Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 8. Global Human Oral Vaccine Sales Market Share by Type (2019-2024)
Table 9. Global Human Oral Vaccine Revenue by Type (2019-2024) & ($ million)
Table 10. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)
Table 11. Global Human Oral Vaccine Sale Price by Type (2019-2024) & (US$/Unit)
Table 12. Global Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 13. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)
Table 14. Global Human Oral Vaccine Revenue by Application (2019-2024)
Table 15. Global Human Oral Vaccine Revenue Market Share by Application (2019-2024)
Table 16. Global Human Oral Vaccine Sale Price by Application (2019-2024) & (US$/Unit)
Table 17. Global Human Oral Vaccine Sales by Company (2019-2024) & (K Units)
Table 18. Global Human Oral Vaccine Sales Market Share by Company (2019-2024)
Table 19. Global Human Oral Vaccine Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Human Oral Vaccine Revenue Market Share by Company (2019-2024)
Table 21. Global Human Oral Vaccine Sale Price by Company (2019-2024) & (US$/Unit)
Table 22. Key Manufacturers Human Oral Vaccine Producing Area Distribution and Sales Area
Table 23. Players Human Oral Vaccine Products Offered
Table 24. Human Oral Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Human Oral Vaccine Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Human Oral Vaccine Sales Market Share Geographic Region (2019-2024)
Table 29. Global Human Oral Vaccine Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Human Oral Vaccine Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Human Oral Vaccine Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Human Oral Vaccine Sales Market Share by Country/Region (2019-2024)
Table 33. Global Human Oral Vaccine Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Human Oral Vaccine Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 36. Americas Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 37. Americas Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 39. Americas Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 40. Americas Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 41. APAC Human Oral Vaccine Sales by Region (2019-2024) & (K Units)
Table 42. APAC Human Oral Vaccine Sales Market Share by Region (2019-2024)
Table 43. APAC Human Oral Vaccine Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Human Oral Vaccine Revenue Market Share by Region (2019-2024)
Table 45. APAC Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 46. APAC Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 47. Europe Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 48. Europe Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 49. Europe Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 51. Europe Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 52. Europe Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Human Oral Vaccine Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Human Oral Vaccine Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Human Oral Vaccine
Table 60. Key Market Challenges & Risks of Human Oral Vaccine
Table 61. Key Industry Trends of Human Oral Vaccine
Table 62. Human Oral Vaccine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Human Oral Vaccine Distributors List
Table 65. Human Oral Vaccine Customer List
Table 66. Global Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Human Oral Vaccine Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Human Oral Vaccine Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Human Oral Vaccine Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Human Oral Vaccine Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Human Oral Vaccine Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Human Oral Vaccine Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Human Oral Vaccine Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Human Oral Vaccine Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Merck Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Human Oral Vaccine Product Portfolios and Specifications
Table 82. Merck Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. GSK Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. GSK Human Oral Vaccine Product Portfolios and Specifications
Table 87. GSK Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. GSK Main Business
Table 89. GSK Latest Developments
Table 90. Sanofi Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi Human Oral Vaccine Product Portfolios and Specifications
Table 92. Sanofi Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Lanzhou Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Lanzhou Institute Human Oral Vaccine Product Portfolios and Specifications
Table 97. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lanzhou Institute Main Business
Table 99. Lanzhou Institute Latest Developments
Table 100. Serum Institute Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Serum Institute Human Oral Vaccine Product Portfolios and Specifications
Table 102. Serum Institute Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Serum Institute Main Business
Table 104. Serum Institute Latest Developments
Table 105. Valneva Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Valneva Human Oral Vaccine Product Portfolios and Specifications
Table 107. Valneva Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Valneva Main Business
Table 109. Valneva Latest Developments
Table 110. Shanghai United Cell Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Shanghai United Cell Human Oral Vaccine Product Portfolios and Specifications
Table 112. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Shanghai United Cell Main Business
Table 114. Shanghai United Cell Latest Developments
Table 115. Bibcol Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Bibcol Human Oral Vaccine Product Portfolios and Specifications
Table 117. Bibcol Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bibcol Main Business
Table 119. Bibcol Latest Developments
Table 120. PaxVax Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. PaxVax Human Oral Vaccine Product Portfolios and Specifications
Table 122. PaxVax Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. PaxVax Main Business
Table 124. PaxVax Latest Developments
Table 125. Vabiotech Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. Vabiotech Human Oral Vaccine Product Portfolios and Specifications
Table 127. Vabiotech Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Vabiotech Main Business
Table 129. Vabiotech Latest Developments
Table 130. Tiantan Biological Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Tiantan Biological Human Oral Vaccine Product Portfolios and Specifications
Table 132. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Tiantan Biological Main Business
Table 134. Tiantan Biological Latest Developments
Table 135. EuBiologics Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. EuBiologics Human Oral Vaccine Product Portfolios and Specifications
Table 137. EuBiologics Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. EuBiologics Main Business
Table 139. EuBiologics Latest Developments
Table 140. Panacea Biotec Ltd Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Panacea Biotec Ltd Human Oral Vaccine Product Portfolios and Specifications
Table 142. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Panacea Biotec Ltd Main Business
Table 144. Panacea Biotec Ltd Latest Developments
Table 145. Bio-Med Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Bio-Med Human Oral Vaccine Product Portfolios and Specifications
Table 147. Bio-Med Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Bio-Med Main Business
Table 149. Bio-Med Latest Developments
Table 150. Halfkin Bio-Pharmaceuticals Basic Information, Human Oral Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolios and Specifications
Table 152. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Halfkin Bio-Pharmaceuticals Main Business
Table 154. Halfkin Bio-Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Human Oral Vaccine
Figure 2. Human Oral Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Oral Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Human Oral Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Oral Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Product Picture of Other
Figure 13. Global Human Oral Vaccine Sales Market Share by Type in 2023
Figure 14. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Human Oral Vaccine Consumed in Child
Figure 16. Global Human Oral Vaccine Market: Child (2019-2024) & (K Units)
Figure 17. Human Oral Vaccine Consumed in Aldult
Figure 18. Global Human Oral Vaccine Market: Aldult (2019-2024) & (K Units)
Figure 19. Global Human Oral Vaccine Sales Market Share by Application (2023)
Figure 20. Global Human Oral Vaccine Revenue Market Share by Application in 2023
Figure 21. Human Oral Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Human Oral Vaccine Sales Market Share by Company in 2023
Figure 23. Human Oral Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Human Oral Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Human Oral Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Human Oral Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Human Oral Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Human Oral Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Human Oral Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Human Oral Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Human Oral Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Human Oral Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Human Oral Vaccine
Figure 74. Industry Chain Structure of Human Oral Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Human Oral Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Human Oral Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Human Oral Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Human Oral Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Human Oral Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Human Oral Vaccine Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Human Oral Vaccine
Figure 2. Human Oral Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Human Oral Vaccine Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Human Oral Vaccine Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Human Oral Vaccine Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Rotavirus Vaccine
Figure 10. Product Picture of Cholera Vaccine
Figure 11. Product Picture of Oral Polio Vaccine
Figure 12. Product Picture of Other
Figure 13. Global Human Oral Vaccine Sales Market Share by Type in 2023
Figure 14. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)
Figure 15. Human Oral Vaccine Consumed in Child
Figure 16. Global Human Oral Vaccine Market: Child (2019-2024) & (K Units)
Figure 17. Human Oral Vaccine Consumed in Aldult
Figure 18. Global Human Oral Vaccine Market: Aldult (2019-2024) & (K Units)
Figure 19. Global Human Oral Vaccine Sales Market Share by Application (2023)
Figure 20. Global Human Oral Vaccine Revenue Market Share by Application in 2023
Figure 21. Human Oral Vaccine Sales Market by Company in 2023 (K Units)
Figure 22. Global Human Oral Vaccine Sales Market Share by Company in 2023
Figure 23. Human Oral Vaccine Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Human Oral Vaccine Revenue Market Share by Company in 2023
Figure 25. Global Human Oral Vaccine Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Human Oral Vaccine Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 28. Americas Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 29. APAC Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 30. APAC Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 31. Europe Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 32. Europe Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Human Oral Vaccine Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Human Oral Vaccine Revenue 2019-2024 ($ Millions)
Figure 35. Americas Human Oral Vaccine Sales Market Share by Country in 2023
Figure 36. Americas Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 37. Americas Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 38. Americas Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 39. United States Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Human Oral Vaccine Sales Market Share by Region in 2023
Figure 44. APAC Human Oral Vaccine Revenue Market Share by Regions in 2023
Figure 45. APAC Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 46. APAC Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 47. China Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Human Oral Vaccine Sales Market Share by Country in 2023
Figure 55. Europe Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 56. Europe Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 57. Europe Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 58. Germany Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Human Oral Vaccine Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Human Oral Vaccine Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Human Oral Vaccine Sales Market Share by Application (2019-2024)
Figure 67. Egypt Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Human Oral Vaccine Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Human Oral Vaccine in 2023
Figure 73. Manufacturing Process Analysis of Human Oral Vaccine
Figure 74. Industry Chain Structure of Human Oral Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Human Oral Vaccine Sales Market Forecast by Region (2025-2030)
Figure 77. Global Human Oral Vaccine Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Human Oral Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Human Oral Vaccine Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Human Oral Vaccine Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Human Oral Vaccine Revenue Market Share Forecast by Application (2025-2030)
